TOMINAGA Mineko | Department of Biophysics, Universidade Federal de Sao Paulo
スポンサーリンク
概要
関連著者
-
TOMINAGA Mineko
Department of Biophysics, Universidade Federal de Sao Paulo
-
Tominaga M
Department Of Biophysics Universidade Federal De Sao Paulo
-
Yamamura Y
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Yabuuchi Y
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Tominaga Mineko
Department Of Biochemistry Institute Of Chemistry University Of Sao Paulo
-
MORI Toyoki
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
TOMINAGA Michiaki
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
YABUUCHI Youichi
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
NAKAIE Clovis
Department of Biophysics, Universidade Federal de Sao Paulo
-
Mori T
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Nakaie Clovis
Department Of Biophysics Universidade Federal De Sao Paulo
-
Mori Toyoki
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
OKADA Yoshio
Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MIRANDA ANTONIO
Department of Biophysics, Escola Paulista de Medidna
-
Miranda Antonio
Department Of Biophysics Universidade Federal De Sao Paulo
-
Okada Yoshio
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Miranda Antonio
Department Of Biophysics Escola Paulista De Medidna
-
JUBILUT Guita
Department of Biophysics, Universidade Federal de Sao Paulo
-
Jubilut Guita
Department Of Biophysics Universidade Federal De Sao Paulo
-
Ogawa H
Second Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Miura Tomisato
弘前大学 理工学研究科物質理工学
-
Paiva Antonio
Department Of Biophysics Universidade Federal De Sao Paulo
-
Nakamura S
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
ONOGAWA Toshiyuki
First Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
ITOH Shuji
First Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
CHIHARA Tomihiko
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
NAKAMURA Shigeki
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
ONOGAWA Toshiyuki
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
YAMASHITA Tatsuya
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
YAMAMURA Yoshitaka
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
AIMOTO Saburo
Institute for Protein Research, Osaka University
-
Yamamura Yoshitaka
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
HOJO Hironobu
Institute for Protein Research, Osaka University
-
Mori Tomonori
(present Address)faculty Of Engineering Towa University
-
CILLI Eduardo
Department of Biophysics, Universidade Federal de Sao Paulo
-
MIRANDA Maria
Department of Biochemistry, Chemistry Institute, Universidade de Sao Paulo
-
Nakagawa Kazuyuki
Second Institute Of New Drug Reserch Otsuka Pharmaceutical Co. Ltd.
-
Okada Y
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Yamashita Tatsuya
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Itoh Shuji
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Itoh Shuji
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Schreier Shirley
Department Of Biochemistry Institute Of Chemistry University Of Sao Paulo
-
Kondo Kazumi
Second Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Miranda Maria
Department Of Biochemistry Chemistry Institute Universidade De Sao Paulo
-
Cilli Eduardo
Department Of Biophysics Universidade Federal De Sao Paulo
-
Cilli Eduardo
Department Of Biochemistry And Technological Chemistry Institute Of Chemistry Unesp
-
Aimoto Saburo
Institude For Protein Research Osaka University
-
Fujiki Hiroyuki
Second Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd
-
YOSHIDA Kenji
Second Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd
-
FUJIKI Hiroyuki
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
YOSHIDA Kenji
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
BARBOSA Simone
Department of Biophysics, Universidade Federal de Sao Paulo
-
POLETTI Erick
Department of Biophysics, Universidade Federal de Sao Paulo
-
ZUKERMAN-SCHPECTOR Julio
Department of Chemistry, Universidade Federal de Sao Carlos
-
MARCHETTO Reinaldo
Department of Biochemistry, Institute of Chemistry
-
Hojo H
Tokai Univ. Kanagawa Jpn
-
Hojo Hironobu
Institute For Protein Research Osaka University
-
Poletti Erick
Department Of Biophysics Universidade Federal De Sao Paulo
-
Barbosa Simone
Department Of Biophysics Universidade Federal De Sao Paulo
-
BEMQUERER Marcelo
Departmento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Mi
-
YAMASHITA Shuji
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
Tsujimi Sachiko
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Yabuuchi Youichi
Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
KWON Yeondae
Institute for Protein Research, Osaka University
-
ZHANG Ruoheng
Department of Chemistry, Peking University
-
FUJIOKA Takafumi
(Present address)Otsuka Pharmaceutical Co., Ltd.
-
TERAMOTO Shuji
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
TAKEMOTO Kazumi
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
HOSOKAWA Tetsumi
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
SUMIDA Takumi
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.
-
OGAWA Hidenori
Second Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.,
-
KNAKAYA Kenji
Second Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.,
-
TOMINAGA Michiaki
Second Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.,
-
YABUUCHI Youichi
Second Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd.,
-
TOMINAGA MICHIAKI
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
OGAWA HIDENORI
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
YO EIYU
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
NAKAGAWA KAZUYUKI
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
Yo E
Otsuka Pharmaceutical Co. Ltd. Tokushima Jpn
-
Sumida T
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Teramoto Shuji
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Kwon Yeondae
Institute For Protein Research Osaka University
-
Zhang Ruoheng
Department Of Chemistry Peking University
-
Knakaya Kenji
Second Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Hosokawa T
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Bemquerer M
Univ. Federal De Minas Gerais Belo Horizonte Bra
-
Bemquerer Marcelo
Departmento De Bioquimica E Imunologia Instituto De Ciencias Biologicas Universidade Federal De Mina
-
Marchetto Reinaldo
Department Of Biochemistry Institute Of Chemistry
-
Zukerman-schpector Julio
Department Of Chemistry Universidade Federal De Sao Carlos
-
Yamashita Shuji
Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Onogawa Toshiyuki
First Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Takemoto Kazumi
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Chihara Tomihiko
2nd Tokushima Institute Of New Drug Research Otsuka Pharmaceutical Co. Ltd.
-
Ogino Y
Teikyo Univ. School Of Medicine Chiba
-
Fujioka Takafumi
(present Address)otsuka Pharmaceutical Co. Ltd.
-
BEMQUERER Marcelo
Department of Biochemistry, Institute of Chemistry, University of Sao Paulo
著作論文
- OPC-21268 Antagonizes Arginine Vasopressin-Induced Vasoconstrictor Response in the Spinally-Anesthetized Dog
- Evaluation of the Trifluoromethanosulfonic Acid/Trifluoroacetic Acid/Thioanisole Cleavage Procedure for Application in Solid-Phase Peptide Synthesis
- Resin Selection Based on the Lability of Peptidyl-Resin Linkage towards HF and TFA Steps : Dependence on the C-Terminal Amino Acid and Peptide Length
- Cardiovascular Effects of the Combination of OPC - 18790 and Dopamine in Halothane - Anesthertized Dogs
- Fmoc-POAC : [(9-Fluorenylmethyloxycarbonyl)-2, 2, 5, 5-tetramethylpyrro-lidine-N-oxyl-3-amino-4-carboxylic Acid] : A Novel Protected Spin Labeled β-Amino Acid for Peptide and Protein Chemistry
- Preparation of Partially Protected Peptide Thioesters Containing a Cysteine Residue and Their Segment Condensation
- Synthesis and Biological Activities of Optically Active 6-[3-(3,4-Dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolinone (OPC-18790)
- Structure-Activity Relationships of Non-peptide Vasopressin V_ Antagonists : 1-(1-Multi-substituted Benzoyl 4-Piperidyl)-3,4-dihydro-2(1H)-quinolinones
- Studies on Positive Inotropic Agents. IV. : Synthesis of 5-(3-Amino-2-hydroxypropoxy)-3,4-dihydro-8-hydroxy-2(1H)-quinolinone Derivatives(Medeicinal Chemistry,Chemical)